Skip to content

Transcranial magnetic cortex Theta stimulation synergistic active sensory training to promote the efficacy and mechanism of upper limb motor function in stroke

Transcranial magnetic cortex Theta stimulation synergistic active sensory training to promote the efficacy and mechanism of upper limb motor function in stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097067
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

iTBS True Stimulation Group:iTBS True Stimulation, Active Sensory Training, Routine Rehabilitation Training
iTBS pseudo-stimulation group:iTBS pseudo-stimulation, active sensory training, routine rehabilitation training
Control group:iTBS pseudo-stimulation, passive sensory training, routine rehabilitation training

Sponsors

The second Rehabilitation Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for stroke in the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018 or the Chinese Guidelines for the Diagnosis and Treatment of Intracerebral Hemorrhage (2019); (2) The first onset, unilateral lesion, or a history of previous onset, but no obvious neurological dysfunction; (3) The patient is 30 years old 21 points); (7) Patients and their families sign informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of epilepsy or a family history of epilepsy; (2) The patient has metal implantation in the skull or has a pacemaker implantation; (3) The patient has sensory loss or hyperesthesia; (4) Severe internal diseases (liver and kidney insufficiency, etc.); (5) Those who cannot complete the treatment cycle and have poor compliance; (6) Patients who are participating in other clinical trials in the same period.

Design outcomes

Primary

MeasureTime frame
Action Research Arm Test;Functional Near-Infrared Spectroscopy;

Secondary

MeasureTime frame
Fugl-Meyer assessment scale, FMA;Semmes-Weinstein;Erasmus MC revised Nottingham sensoryassessment scale, Em-NSA;Embodied Sense of Self Scale;Activities of Daily Living;Resting Motor Threshold;Motor evoked potential;

Countries

China

Contacts

Public ContactYichen Jiang

School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine

shtcmjyc@163.com+86 51322406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026